These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15868023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J, Gu F, Vasudevan SG.
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [Abstract] [Full Text] [Related]

  • 5. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP, Kuo YC, Selling BH, Li Q, Sardesai NY, Kim JJ, Weiner DB.
    Vaccine; 2009 Oct 30; 27(46):6444-53. PubMed ID: 19580892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S, Rothman A.
    Curr Opin Infect Dis; 2006 Oct 30; 19(5):429-36. PubMed ID: 16940865
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S, Paci M.
    FEBS J; 2007 Jun 30; 274(12):2986-3002. PubMed ID: 17509079
    [Abstract] [Full Text] [Related]

  • 16. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
    Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G.
    Nat Med; 2003 Jul 30; 9(7):921-7. PubMed ID: 12808447
    [Abstract] [Full Text] [Related]

  • 17. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B, Chanthavanich P, Gimenez S, Sirivichayakul C, Sabchareon A, Begue S, Yoksan S, Luxemburger C, Lang J.
    Vaccine; 2004 Sep 09; 22(27-28):3563-74. PubMed ID: 15315835
    [Abstract] [Full Text] [Related]

  • 18. Dengue and dengue haemorrhagic fever: implications of host genetics.
    Chaturvedi U, Nagar R, Shrivastava R.
    FEMS Immunol Med Microbiol; 2006 Jul 09; 47(2):155-66. PubMed ID: 16831202
    [Abstract] [Full Text] [Related]

  • 19. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B, Boots M.
    J Theor Biol; 2006 Sep 21; 242(2):337-46. PubMed ID: 16631802
    [Abstract] [Full Text] [Related]

  • 20. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S, Pilankatta R, Khanna N, Swaminathan S.
    Vaccine; 2009 Oct 09; 27(43):6011-21. PubMed ID: 19665609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.